Vogelxo FDA Approval History
Vogelxo (testosterone) transdermal gel is an androgen indicated for testosterone replacement therapy in males with hypogonadism.
Development Timeline for Vogelxo
|Jun 5, 2014||Approval Upsher-Smith Receives Final NDA Approval For Vogelxo (testosterone) Gel|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.